Researchers from The Ohio State University and Nationwide Children's Hospital in Columbus, OH, have shown that therapeutic nanocarriers engineered from adult skin cells can curb inflammation and tissue injury in damaged mouse lungs, hinting at the promise of a treatment for lungs severely injured by infection or trauma. The nanocarriers are extracellular vesicles similar to the ones circulating in humans' bloodstream and biological fluids that carry messages between cells. The hope is that a drop of solution containing these nanocarriers, delivered to the lungs via the nose, could treat acute respiratory distress syndrome, one of the most frequent causes of respiratory failure that leads to putting patients on a ventilator.
An official website of the United States government.